Literature DB >> 16305706

In vitro fertilization in Sweden: maternal characteristics.

Bengt Källén1, Orvar Finnström, Karl-Gösta Nygren, Petra Otterblad Olausson.   

Abstract

BACKGROUND: Deliveries among women who had an in vitro fertilization (IVF) are characterized by increased risks for both the mother and the infant/child. Part of these effects may be due to maternal characteristics.
METHODS: Using reports from all clinics performing IVF in Sweden, 12 186 women who gave birth after such procedures were identified (13 261 deliveries, 16 280 infants born). Various social and medical characteristics of the women were studied and compared with all women giving birth. Information was retrieved by interviews in early pregnancy or by linkage with various registers.
RESULTS: Women who had IVF were older than other women who gave birth and were older after standard IVF than after intracytoplasmatic sperm injection (ICSI). They were more often of first parity and smoked less than other delivered women. There were more women with high body mass index: they worked outside home less often and were more often of Swedish nationality. Women who had standard IVF had more previous miscarriages than expected, but this was not true for women who had ICSI. Their pattern of drug usage differed from that of other women who had given birth.
CONCLUSIONS: Women who underwent IVF and gave birth showed marked deviations from other women who gave birth. Some of these characteristics may help to explain the increased risks associated with these procedures. Women who had ICSI were less deviating than women who had standard IVF.

Entities:  

Mesh:

Year:  2005        PMID: 16305706     DOI: 10.1111/j.0001-6349.2005.00858.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications.

Authors:  Bengt Källén; Petra Otterblad Olausson
Journal:  Eur J Clin Pharmacol       Date:  2007-01-30       Impact factor: 2.953

2.  Risk of Adverse Obstetric Outcomes and the Abnormal Growth of Offspring in Women with a History of Thyroid Cancer.

Authors:  Geum Joon Cho; So-Youn Kim; Hoi Chang Lee; Kyu-Min Lee; Sung Won Han; Min-Jeong Oh; Teresa K Woodruff
Journal:  Thyroid       Date:  2019-05-09       Impact factor: 6.568

3.  The pregnancy health and birth outcomes of women who underwent assisted reproductive technology: Results of a national survey.

Authors:  Lii-Shung Huang; Chi-Hwa Yen; Shu-Hsin Lee; Bih-Ching Shu; For-Wey Lung; Ching-Pyng Kuo; Wei-Ya Wu; Angel Yen-Chiao; Yen-Ju Lin; Hui-Sheng Lin; Ming-Chih Chou; Meng-Chih Lee
Journal:  Iran J Reprod Med       Date:  2011

4.  Changing seasonal variation in births by sociodemographic factors: a population-based register study.

Authors:  J Dahlberg; G Andersson
Journal:  Hum Reprod Open       Date:  2018-09-29

5.  Multiple superovulations alter histone modifications in mouse early embryos.

Authors:  Shou-Bin Tang; Lei-Lei Yang; Ting-Ting Zhang; Qian Wang; Shen Yin; Shi-Ming Luo; Wei Shen; Zhao-Jia Ge; Qing-Yuan Sun
Journal:  Reproduction       Date:  2019-06       Impact factor: 3.906

6.  Assisted Reproductive Technology affects developmental kinetics, H19 Imprinting Control Region methylation and H19 gene expression in individual mouse embryos.

Authors:  Patricia Fauque; Pierre Jouannet; Corinne Lesaffre; Marie-Anne Ripoche; Luisa Dandolo; Daniel Vaiman; Hélène Jammes
Journal:  BMC Dev Biol       Date:  2007-10-18       Impact factor: 1.978

7.  Impact of Stress and Financials on Romanian Infertile Women Accessing Assisted Reproductive Treatment.

Authors:  Roxana Margan; Madalin-Marius Margan; Corneluta Fira-Mladinescu; Salomeia Putnoky; Ioana Tuta-Sas; Radu Bagiu; Zoran Laurentiu Popa; Elena Bernad; Ioana Mihaela Ciuca; Felix Bratosin; Oana Codruta Miloicov-Bacean; Brigitha Vlaicu; Amadeus Dobrescu
Journal:  Int J Environ Res Public Health       Date:  2022-03-10       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.